Article

Pfizer commits $800,000 to EyeCare America program

New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.

New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.

The public service program of the Foundation of the American Academy of Ophthalmology (AAO) is a nationwide effort through which 7,300 AAO members volunteer to offer glaucoma eye exams and treatment, if necessary, at no cost to eligible uninsured people. The program is designed for U.S. citizens or legal residents who have not had an eye exam in the past 12 months, are at increased risk for glaucoma, and do not receive health care through a managed-care organization or the U.S. Department of Veterans Affairs.

Pfizer Ophthalmics presented the check to EyeCare America at the AAO annual meeting in November.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.